Montauk Renewables, Inc. (MNTK) focuses on recovering and processing biogas from landfills and other sources to produce renewable natural gas (RNG) and electricity. I reviewed four current analyst targets: B. Riley Securities at $1.50, UBS at $1.60, Scotiabank at $2.00, and Clear Street at $3.00 with a Buy rating. The average comes to roughly $2.03, which rounds neatly to the $2.00 central target, with the full range spanning $1.50 to $3.00. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
That spread highlights differing views on the same fundamentals. Most firms in the $1.50–$2.00 range hold neutral ratings, citing margin pressure, softer RIN pricing, and elevated capital needs. Clear Street’s higher target reflects greater optimism on RNG expansion. Several targets have been lowered over the past year, pointing to cautious sentiment overall.
At a recent close near $1.17, reaching $2.00 would mean about 71% upside. The stock remains well below its 52-week high of roughly $3.28, so even a move to the target would recover only part of the earlier drop. In my view, sustained margin improvement, steadier RIN prices, and solid execution at sites like the Montauk Ag facility in Turkey, North Carolina, would be essential.
The latest quarter showed revenue up about 10.9% year over year, yet net income, adjusted EBITDA, and EPS all came in softer than hoped. Management kept 2026 revenue guidance in the $198 million to $216 million range, which aligns closely with expectations and leaves little room for an immediate positive shift without clearer profitability gains.
The 52-week range of roughly $0.94 to $3.28 sets the technical backdrop. The stock has been consolidating near the bottom, with a post-earnings rebound lifting it from around $0.95 toward $1.37 intraday before settling near $1.17. Support sits at the psychological $1.00 level and the $0.94 low, while $1.50 and $2.00 serve as round-number resistance on any recovery. The longer-term trend remains downward, so clearing several overhead hurdles would be required for a move toward $2.00.
Analyst targets typically look out about 12 months. I’m watching upcoming quarterly results and guidance, RIN and renewable fuel credit trends, progress at the Turkey, North Carolina facility, adjusted EBITDA margins, and any target revisions. Regulatory changes in renewable fuel standards also matter directly to the economics. None of this predicts the target will be reached.
From what I see, combining fundamental work with automated signals can help track momentum shifts in real time. I often turn to Tickeron’s AI Daily Buy/Sell Signals when following names like MNTK, as the system monitors thousands of stocks and generates Buy, Sell, or Hold signals based on technical behavior and market conditions. This approach complements the review of analyst targets and earnings data without replacing core research.
The $2.00 target, derived from averaging four analyst estimates between $1.50 and $3.00, implies roughly 71% upside from near $1.17. Support for reaching it rests on RNG growth, maintained guidance, and possible RIN recovery. Risks center on margin weakness, project execution, liquidity needs, and mixed ratings. Near the 52-week low with cautious sentiment overall, the target represents a high-uncertainty scenario that hinges on margin recovery and successful project delivery in coming quarters.
I’ve found AI Daily Buy/Sell Signals from Tickeron useful for monitoring stocks like MNTK. The platform applies artificial intelligence to scan thousands of equities and ETFs, producing real-time Buy, Sell, or Hold signals based on technical patterns and market shifts. It serves as a practical complement to fundamental analysis when tracking momentum or identifying potential changes in trend.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
MNTK saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 10, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 54 instances where the indicator turned negative. In 50 of the 54 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MNTK as a result. In 75 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
MNTK moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MNTK crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MNTK's RSI Indicator exited the oversold zone, 27 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +15.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNTK advanced for three days, in 221 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
MNTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.464) is normal, around the industry mean (2.284). P/E Ratio (54.400) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (1.709) is also within normal values, averaging (48.960).
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. MNTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ChemicalsSpecialty